Influence of stent surface topography on the outcomes of patients undergoing coronary stenting: A randomized double-blind controlled trial
✍ Scribed by Alban Dibra; Adnan Kastrati; Julinda Mehilli; Jürgen Pache; Randolf von Oepen; Josef Dirschinger; Albert Schömig
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 130 KB
- Volume
- 65
- Category
- Article
- ISSN
- 1522-1946
No coin nor oath required. For personal study only.
✦ Synopsis
The objective of this study was to examine the relationship between stent surface topography and outcome in patients undergoing implantation of stents with rough and smooth surfaces. Surface topography is considered an important determinant of the bare stent performance. Specifically designed rough surface may increase the drugstoring capacity of stents but its direct impact on the risk of thrombosis and restenosis is not known. A total of 200 patients with significant stenosis in native coronary vessels were randomly assigned in a double-blind way to receive either a rough or a smooth-surface stent. The primary endpoint of the study was late lumen loss. Secondary endpoints included angiographic restenosis and clinical outcomes. The study was designed to test the equivalence of rough-surface stents to smooth-surface stents with respect to late lumen loss based on a noninferiority margin of 0.20 mm. Follow-up angiography was performed in 77% of the patients. Late lumen loss was 1.0 6 0.7 mm in the rough-surface stent group and 1.2 6 0.7 mm in the smooth stent surface group with a mean difference of 20.20 mm (95% CI 5 20.43 to 0.02) between the two stents (P < 0.001 from test for equivalence and P 5 0.08 from test for superiority). Angiographic restenosis rates were 25% with rough-surface stents and 35% with smoothsurface stents (P 5 0.19). These results show that a rough stent surface does not increase late lumen loss after stent implantation as compared with a conventional smooth stent surface.
📜 SIMILAR VOLUMES
## Abstract The objective of this study was to investigate the effect of trapidil 200 mg t.i.d. in preventing the occurrence of death, of myocardial infarction and the need for repeat revascularization at 12 months after balloon PTCA with or without stenting. Coronary restenosis after stenting is s
## Abstract Safinamide is an α‐aminoamide with both dopaminergic and nondopaminergic mechanisms of action evaluated as an add‐on to dopamine agonist (DA) therapy in early‐stage PD. In this 24‐week, double‐blind study, patients with early PD receiving a stable dose of a single DA were randomized to
## Abstract ## Aims To develop and validate a scale that is applicable in Belgium to investigate the aspects of female patients' satisfaction with urodynamic consultation, and to use it to measure the impact of a detailed explanatory leaflet on their satisfaction. ## Materials and Methods Questi